A Pilot Study of Creative Arts Interventions for Neurology Inpatients
1 other identifier
interventional
33
1 country
1
Brief Summary
The purpose of the study is to assess the feasibility of a Creative Artists Program intervention with epilepsy and headache patients admitted to Dartmouth-Hitchcock Medical Center for care by the Department of Neurology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 19, 2017
CompletedFirst Submitted
Initial submission to the registry
April 13, 2018
CompletedFirst Posted
Study publicly available on registry
May 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedJuly 18, 2018
July 1, 2018
9 months
April 13, 2018
July 16, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of conducting a creative arts intervention study
The feasibility of the creative intervention will be determined by the completion rates of the initial intervention attempts. If less than 50% of patients complete the intervention it will be deemed unfeasible in the current format.
Through study completion, approximately 1 year
Secondary Outcomes (5)
Change in patient anxiety before and after the intervention
Each patient will be assessed at baseline (Day 1) and after the intervention (approximately Day 3 - 21).
Change in patient distress before and after the intervention
Each patient will be assessed at baseline (Day 1) and after the intervention (approximately Day 3 - 21).
Change in patient depression before and after the intervention
Each patient will be assessed at baseline (Day 1) and after the intervention (approximately Day 3 - 21).
Change in frequency of as-needed pain medication use
Each patient as-needed medication use will be assessed after the arts intervention and until discharge from the hospital (approximately Day 3 - 21).
Length of hospital stay
Each patient's admission duration (approximately 3 - 21 Days).
Study Arms (1)
Artist Intervention
OTHEROne of the three artists (visual artist, music therapist, creative writer) will work with subjects for up to 90 minutes.
Interventions
Type of artist intervention will be determined by the subject and the assigned artist.
Eligibility Criteria
You may qualify if:
- Age \> or = 18 years
- Diagnosis of refractory chronic epilepsy, status migrainosus, or chronic daily headache
- Elective admission to the Dartmouth-Hitchcock Medical Center Epilepsy monitoring unit or Headache service
- Capable of giving informed consent
You may not qualify if:
- Active psychiatric illness that prohibits safe visitation by artists
- Impairment of vision or hearing that would prohibit able to participate with participation in instructions necessary for the interventions.
- Active general medical condition that would impair consciousness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 13, 2018
First Posted
May 11, 2018
Study Start
September 19, 2017
Primary Completion
June 1, 2018
Study Completion
June 30, 2018
Last Updated
July 18, 2018
Record last verified: 2018-07